Biosimilars Loom Large As Sandoz Sets Stage For Spinoff

Capital Markets Days Highlight Off-Patent Biologics As Major Opportunity After Separation

 
• By David Wallace
  
Company sign reading Sandoz A Novartis Division
Sandoz will soon no longer be a Novartis division • Source: Shutterstock

More from Strategy

More from Business